Ambrx Biopharma OverviewAmbrx Biopharma Gross Profit
Gross Profit analysis for AMAM.
Quarterly Gross Profit
$53000.00
↓ 97.64% YoY
As of Sep 30, 2023
Annual Gross Profit (TTM)
$3.44M
↓ 45.48% YoY
Trailing 12 months ending Sep 30, 2023
Ambrx Biopharma OverviewGross Profit analysis for AMAM.
As of Sep 30, 2023
Trailing 12 months ending Sep 30, 2023